Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 323 of 323 publications.

Albino AP, Huang X, Jorgensen ED, Yang J, Gietl D, Traganos F, Darzynkiewicz Z. Induction of H2AX phosphorylation in pulmonary cells by tobacco smoke: a new assay for carcinogens. Cell cycle. 2004 Aug 3;3(8):1062-8. doi: 10.4161/cc.3.8.988

Mauskopf J, Candrilli S, Segal R, Schaber C, Tsai H. The current burden of respiratory distress syndrome (RDS) in very low birth-weight(VLBW) infants. Pediatr Res. 2004 Jan 1;55(4):549A.

Hopkinson NS, Nickol AH, Payne J, Hawe E, Man WD, Moxham J, Montgomery H, Polkey MI. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):395-9.

Santanello NC, DeMuro-Mercon CJ, Philip G, Schenkel E, Shah SR. Impact of seasonal allergic rhinitis on sleep: importance rating study. Poster presented at the American Thoracic Society; May 2003.

Santanello NC, DeMuro-Mercon CJ, Philip G, Ratner PH. Differences in functioning and well-being based on sleep quality in allergic rhinitis. Poster presented at the European Academy of Allergology and Clinical Immunology; May 2003.

Rothman KJ, Wentworth CE. Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation. Epidemiology. 2003 Jan;14(1):55-9.

Johannes CB, Schneider G, Dube TJ, Davis KJ, Walker AM. The risk of non-vertebral fracture related to inhaled corticosteroid exposure among adults with physician-diagnosed respiratory disease. Poster presented at the Chest 2003, The American College of Chest Physicians Annual Meeting; 2003. Orlando, FL.

Mansfield CA, Hubbell B. The cost of asthma: cost of illness estimates of acute asthma episodes. Presented at the Second World Congress of Environmental and Resource Economists; June 2002. Monterey, CA.

Hauber BHIV, Earnshaw SR, Spencer MD, Candrilli SD. Estimating the incidence and duration of exacerbations in chronic obstructive pulmonary disease. Poster presented at the 98th Annual Conference of the American Thoracic Society; May 2002.

Spencer MD, Hauber BHIV, Earnshaw SR, Candrilli SD. Estimating lung function decline based on ats staging classifications, and the effect of tobacco smoking in copd patients. Poster presented at the American Thoracic Society 98th International Conference; May 2002.

Erickson SR, Munzenberger PJ, Plante M, Kirking DM, Hurwitz M, Vanuya R. Influence of sociodemographics on the health-related quality of life of pediatric patients with asthma. J Asthma. 2002 Apr 1;39(2):107-17.

Loughlin JE, Cole JA, Rothman KJ, Johnson ES. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol. 2002 Jan 1;88(3):319-25.

Mauskopf JA, Bell LN, Neighbors DM, Dombeck M. Estimating the return on investment for tuberculosis drugs. Poster presented at the 2001 ISPOR 4th Annual European Congress; November 11, 2001. Cannes, France. [abstract] Value Health. 2001 Sep; 4(6):446.

Poulos C, Smith VK. A preliminary analysis of economic factors affecting childhood asthma. Presented at the Add Health Users Workshop. National Institutes of Health; August 2001. Bethesda, MD.

DeMuro-Mercon CJ, Turpin J, Santanello N. Validation of 2 new instruments for assessing the impact of exercise induced asthma on physical activity. Poster presented at the World Asthma Meeting; July 2001.

DeMuro-Mercon CJ, Turpin J, Santanello N, Firriolo K, Edelman J. Montelukast improves asthma quality of life when added to fluticasone. Poster presented at the 57th Meeting of the American Academy of Allergy, Asthma, and Immunology; March 2001. New Orleans, LA.

Santanello NC, Demuro-Mercon C, Davies G, Ostrom N, Noonan M, Rooklin A, Knorr B. Validation of a pediatric asthma caregiver diary. J Allergy Clin Immunol Pract. 2000 Nov 1;106(5):861-6.

Quittner AL, Sweeny S, Watrous M, Munzenberger P, Bearss K, Gibson NA, Fisher LA, Henry B. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis. J Pediatr Psychol. 2000 Sep 1;25(6):403-14.

Rothman KJ, Cann CI. The smoking gun? Epidemiology. 2000 Sep;11(5):485-6.

Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet. 2000 Jul 28;370(9584):336-41.

Steffensen FH, Sorensen HT, Gillman MW, Rothman KJ, Sabroe S, Fischer P, Olsen J. Low birth weight and preterm delivery as risk factors for asthma and atopic dermatitis in young adult males. Epidemiology. 2000 Mar;11(2):185-8.

Castellsague J, Garcia-Rodriguez LA, Perez-Gutthann S, Agostinis L, Cattaruzi C, Troncon MG. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population. Respir Med. 1999 Oct 1;93(10):709-14.

Rothman KJ. Causes and Risks. In: Clark MA, editors. Pulmonary disease. Defense mechanisms and populations at risk. Lexington: KY. Tobacco and Health Research Institute (THRI); 1977.